Thomas Grader-Beck, MD - Sjögren’s Disease and the B-Cell Frontier: What Clinicians Need to Know Now to Prepare for Future Therapies

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/FBZ865. CME/NCPD/AAPA credit will be available until January 26, 2027.

Sjögren’s Disease and the B-Cell Frontier: What Clinicians Need to Know Now to Prepare for Future Therapies

In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and PVI, PeerView Institute for Medical Education. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Support
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Disclosure information is available at the beginning of the video presentation.